Skip to main content
Clinical Trials/DRKS00006236
DRKS00006236
Active, not recruiting
未知

Extracorporeal Shock Wave Therapy for secondary wound healing of diabetic foot syndrome – ESWT - ESWT

eitender Ärztliche Direktor Universitätsklinikum Freiburg0 sites6 target enrollmentJune 18, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
E10.74
Sponsor
eitender Ärztliche Direktor Universitätsklinikum Freiburg
Enrollment
6
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 18, 2014
End Date
March 31, 2018
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
eitender Ärztliche Direktor Universitätsklinikum Freiburg

Eligibility Criteria

Inclusion Criteria

  • patients with diabetic foot syndrome:
  • \-chronic wound since at least 4 weeks
  • \- Wagner stage 1\-2
  • \-ABI (ankle\-brachial\-index) 0\.7\-1\.2
  • \- Patients with Diabetic mellitus receive a therpaiy HbA1c\<\=7,5%
  • \- appropriate pressure relief
  • General inclusion criteria:
  • \-signed declaration of informed consent and data protection
  • \-males and females
  • \-older than 18 years

Exclusion Criteria

  • \-Presence of an ABI (\=Ankle Brachial Index) of \< 0\.7 \> 1,2
  • \- patient with malignant disease
  • \- Wagner stage 3\-5
  • \- osteitis/Osteomyelitis in wound region
  • \- untreated wound infektion (leukocytes\>12 000/miicroliter)
  • \- General exclusion criteria:
  • \- pregnancy
  • \- participation in other clinical studies either concurrently or within the last 30 days
  • \- Noncompliance (Patient does not wear the shoes, does not carry out local therapy or terminates it,
  • \- Evidence of any major life\-threatening or serious medical condition (sytemic infection)

Outcomes

Primary Outcomes

Not specified

Similar Trials